the aid library

LIST OPTIONS

Filter

9932

журнал психиатрия 1`2014

Гаврилова С.И, Aлесенко А.В., Mолочкина Е.М. et al. ФГБНУ «Научный центр психического здоровья» (2014) C2

Материалы научно-практической конференции с международным участием «Достижения в нейробиологии и терапии болезни Альцгеймера», посвященной памяти профессора Э.�... more

Download (85)

View PDF (62)

Financing the Pandemic Cycle: Prevention, Preparedness, Response, and Recovery and Reconstruction

Fan V. Y., Kim S., Pineda D., et al. Center for Global Development (2024) CC

The COVID-19 pandemic exposed critical gaps in the global response to health crises, particularly in the financing of pandemic prevention, preparedness, response, recovery, and reconstruction. This chapter presents a comprehensive framework for pandemic financing that spans the entire pandemic cycle... more

External Link

External Link (76)

Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

Dingle, A.; Schäferhoff, M.; Borghi, J. et al. The Lancet (2020) CC

Background Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul...d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017. Methods Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators. Findings After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million). Interpretation Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention. Funding Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health. more

External Link

External Link (58)

National spending on health by source for 184 countries between 2013 and 2040

Dieleman, J.; Templin, T.; Sadat, N. et al. (2016) CC

A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at simi...lar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected. Methods We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks. Findings Global spending on health is expected to increase from US$7·83 trillion in 2013 to $18·28 (uncertainty interval 14·42–22·24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2·7% (1·9–3·4) in high-income countries, 3·4% (2·4–4·2) in upper-middle-income countries, 3·0% (2·3–3·6) in lower-middle-income countries, and 2·4% (1·6–3·1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0·03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending. Interpretation Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action. Funding Bill & Melinda Gates Foundation. more

Download (446)

View PDF (528)

Ghidul pentru diagnosticul si tratamentul tuberculozei la copii

Prof. Dr. I. P. Stoicescu, Dr. Marilena C., Dr. A. Macri, et al. Institutul National de Cercetare-Dezvoltare in Sanatate Bucuresti (2006) C2

Download (324)

View PDF (518)

Alzheimer's disease facts and figures

J. Gaugler, Ph.D.; B. James, Ph.D.; T. Johnson, Ph.D., et al. Alzheimer's Association (2018) C2

Includes a Special Report on the Financial and Personal Benefits of Early Diagnosis 2018 Alzheimer’s Disease Facts and Figures is a statistical resource for U.S. data related to Alzheimer’s disease, the most common cause of dementia. Background and context for interpretating the data are con... more

External Link

Current Treatments to Control African Trypanosomiasis and One Health Perspective

Venturelli, A.; Tagliazucchi, L.; Lima, C.; Venuti, F. et al. MDPI Microorganisms (2022) CC

Human African Trypanosomiasis (HAT, sleeping sickness) and Animal African Trypanosomiasis (AAT) are neglected tropical diseases generally caused by the same etiological agent, Trypanosoma brucei. Despite important advances in the reduction or disappearance of HAT cases, AAT represents a risky reserv... more

Download (160)

View PDF (324)

A summary of the new GINA strategy: a roadmap to asthma control

Reddel, H. K.; Bateman, E. D.; Becker, A.; et al. (2015) CC2

Over the past 20 years, the Global Initiative for Asthma (GINA) has regularly published and annually updated a global strategy for asthma management and prevention that has formed the basis for many national guidelines. However, uptake of existing guidelines is poor. A major revision of the GINA r... more

Download (133)

View PDF (142)

Provider-initiated HIV testing and TB screening in the era of universal coverage: Are the right people being reached? A cohort study in Blantyre, Malawi

Mair, L.; Corbett, E. L.; Feasey, H. R. A.; et al. PLOS One (2020) CC2

In a prospective cohort study in Bangwe primary care clinic, Blantyre, Malawi, all adults (18 years or older) presenting with an acute illness were screened for TB symptoms (cough, fever, night sweats, weight loss). Demographic characteristics were linked to exit interview by fingerprint bioidentifi... more

External Link

HIV care in Central and Eastern Europe: How close are we to the target?

D. Gokengina,; C. Opreab; J. Begovacc; A. Horban; et al. International Journal of Infectious Diseases; International Society for infectious Diseases ; Elsevier (2018) C2

International Journal of Infectious Diseases 70 (2018) 121–130 https://doi.org/10.1016/j.ijid.2018.03.007 1201-9712/© 2018 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license (http://cr... more

External Link

Tuberculosis control in prisons: current situation and research gaps

M. Dara, C. D. Acosta, M. V. S. Vinklers Melchers, et al. International Journal of Infectious Diseases (2015) C2

International Journal of Infectious Diseases 32 (2015) 111–117

External Link

High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening
recommended

L. Telisinghe, K. L. Fielding, J. L. Malden, et al. PLOS One (2014) CC

PLoS ONE 9(1): e87262. doi:10.1371/journal.pone.0087262

External Link

Les maladies chroniques non transmissibles chez les militaires sénégalais: étude transversale en 2013

Aziz N. A., S. S. Mohamed, T. A. Badara et. al. Pan African - Medical Journal (2015) C2

Les maladies chroniques non transmissibles (MCNT) constituent un problème de santé publique. La transition épidémiologique coexiste avec les maladies infectieuses. En Afrique subsaharienne, leur ampleur est peu connue et l'OMS recommande aux pays à faible et moyen revenu de réaliser des enquê... more

External Link

Achieving UNAIDS 90-90-90 targets for pregnant and postpartum women in sub-Saharan Africa: progress, gaps and research needs

L. L. Abuogi; J. M. Humphrey; C. Mpody, et al. Journal of Virus Eradication (2018) CC

Journal of Virus Eradication 2018; 4 (Supplement 2): 33–39

Download (216)

View PDF (345)

Progress towards elimination of lymphatic filariasis in the Americas region

G. Fontes, da Rocha, E. M. M.; Carvalho Scholte, R. G.; et al. International Health (2020) C1

In South and Central America, lymphatic ﬁlariasis (LF) is caused by Wuchereria bancrofti, which is transmitted by Culex quinquefasciatus, the only vector species in this region. Of the seven countries considered endemic for LF in the Americas in the last decade, Costa Rica, Suriname and Trinidad a... more

Download (253)

View PDF (399)

The Impact of Climate Change on Health: Reducing Risks and Increasing Resilience in the Era of COVID-19

Machalaba; C.; Bouley, T. A.; Nunziata, K. R.; et al. (2021) C1

The climate crisis has many consequences – among them widespread health impacts that will lead to immense societal, ecological, and economic harm. Over the past two decades multiple large-scale reviews on climate change and health have made clear the need for a multi-sectoral approach to target t... more

Download (160)

View PDF (160)

Understanding and controlling asthma in Latin America: A review of recent research informed by the SCAALA programme

Cooper, P. J.; Figueiredo, C. A.; Rodriguez, A.; et al. (2023) CC2

Asthma is the most common chronic respiratory disease (CRD) worldwide and is estimated to affect 262 million causing significant mortality and morbidity, and has emerged as an important public health problem in many Latin American (LA) countries over the last 30 or so years. LA is a highly diverse r... more

Download (407)

View PDF (1205)

Scaling up of collaborative TB/HIV activities in concentrated HIV epidemic settings - A case study from India

A. Kanchar; Dr. A. Kumar; Dr. R. S. Gupta; et al. World Health Organization (WHO) (2015) C_WHO

Download (245)

View PDF (261)

“I would love if there was a young woman to encourage us, to ease our anxiety which we would have if we were alone”: Adapting the Mothers2Mothers Mentor Mother Model for adolescent mothers living with

N. B. Carbone; J. Njala; D. J. Jackson; et al. PLOS One; PubMed.gov (2019) CC

PLOS ONE | https://doi.org/10.1371/journal.pone.0217693 June 7, 2019

Download (257)

View PDF (263)

COComportamiento de la tuberculosis y avances en la implementacion del plan estrategico hacia el fin de la tuberculosis en Colombia 2016-2025.

Gómez, F.R.; L. A. M. Osorio, D. I. Cárdenas Gamboa et al. Ministerio de Salud Colombia (2020) CC

La tuberculosis persiste como una grave problemática para la salud pública a nivel internacional y nacional dado que continúa siendo una de las diez primeras causas de morbilidad y mortalidad derivada de enfermedades infectocontagiosas en la población.

High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening recommended

High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening
recommended